ArticlePloS one2026
Study protocol for a mixed methods convergent investigation of family domestic and sexual violence in multiple sclerosis and broader neurology in Australia.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople with disabilities experience disproportionately high rates of family, domestic, and sexual violence (FDSV), yet recognition and response in neurological healthcare, including multiple sclerosis (MS), remain underexplored. The study is informed by evidence-based frameworks for healthcare responses to family, domestic, and sexual violence, including the World Health Organization's Listen, Inquire, Validate, Enhance safety, Support access (LIVES) approach and Victoria, Australia's Multi-Agency Risk Assessment and Management (MARAM) framework. These models share core principles of trauma-informed practice, structured risk assessment, and coordinated response, providing a foundation for investigating how such approaches can be applied and adapted within neurological care.
objectivesThis study aims to estimate the prevalence and describe the forms of FDSV experienced by people with MS, identify associated social, clinical, and contextual factors, and document current neurology practices for recognising and responding to FDSV. Comparative qualitative analysis across MS, epilepsy, and headache will assess whether findings are condition-specific or shared across neurology to inform future strategies. METHODS AND ANALYSIS: A convergent mixed-methods design will be applied across six study arms. Quantitative components include screening approximately 1,000 people with MS, registry linkage, and surveys with at least 100 participants assessing trauma exposure, wellbeing, and disability-related violence. Qualitative interviews with people with MS, epilepsy, and headache, and clinicians (n ≈ 64 total) will explore experiences, clinical practice, and barriers and enablers to implementing evidence-based frameworks. Data will be integrated through triangulation to identify convergent and divergent patterns. DISCUSSION: Findings will provide foundational evidence on how MS and other neurological conditions intersect with experiences of FDSV, guiding trauma-informed training, policy, and practice across neurology. REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN390279.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.